Amlodipine Besylate And Olmesartan Medoxomil Tablet
Product Images NDC 27241-086

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Olmesartan Medoxomil (NDC 27241-086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine And Olmesartan 10 20

FDA Label Image

Amlodipine And Olmesartan 10 40

This text is a description of a medication. The medication contains 139mg of Amlodipine, equivalent to 10mg of Amlodipine Besylate USP, and 40mg of Olmesartan Medoxomil USP. The medication is sold in a bottle containing 30 tablets, and the recommended dosage is 2 tablets as indicated in the package insert. The medication should be stored at a temperature of 25°C with excursions permitted up to 30°C or 86°F. It is manufactured by Ajanta Pharma USA Inc. in India.*

FDA Label Image

Amlodipine And Olmesartan 5 20

Each tablet contains 69 mg of Amlodipine Besylate and 20 mg of Olmesartan Medoxomil. The tablets come in a bottle of 30 and should be stored at 25°C (77°F). The dosage and use information can be found in the package insert. This product is marketed by Ajanta Pharma USA Inc. and made in India.*

FDA Label Image

Amlodipine And Olmesartan 5 40

FDA Label Image

Amlodipine And Olmesartan Fig1

FDA Label Image

Amlodipine And Olmesartan Fig2

FDA Label Image

Amlodipine And Olmesartan Fig3

FDA Label Image

Amlodipine And Olmesartan Fig4

FDA Label Image

Amlodipine And Olmesartan1

FDA Label Image

Amlodipine And Olmesartan2

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.